Sorry, you need to enable JavaScript to visit this website.

Five Steps to Good Health: Essential Advice for Men

It’s become a cliché that many men don’t take care of their health as well as women do and that they’re less likely to see a doctor. But is the cliché true? Unfortunately, data offer some support. Men are less likely to keep up with regular check-ups and get medical care than women are. At Pfizer, we want to change these trends and empower men with the information they need to take control of their health. June is Men’s Health Month making it a great time to remind the dads in our lives about the importance of a healthy lifestyle.

Pfizer Provides Update on U.S. Regulatory Review of TALZENNA in Combination with XTANDI for Broader Use in Metastatic Castration-Resistant Prostate Cancer

New York, June 13, 2025 – Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration’s (FDA) decision on the supplemental New Drug Application (sNDA) for TALZENNA® (talazoparib) in combination with XTANDI® (enzalutamide) for men with metastatic castration-resistant prostate cancer (mCRPC).

Subscribe to Updates